Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.5763
H.R.5763: Prostate Cancer Misdiagnosis Elimination Act of 2016
About This Bill
- This bill was introduced in the 114th Congress
- This bill is primarily about health
- Introduced July 13, 2016
- Latest Major Action Aug. 1, 2016
Bill Sponsor
Bill Cosponsors
3 (2 Democrats, 1 Republican)
Bill Summary
Prostate Cancer Misdiagnosis Elimination Act of 2016 This bill specifies that, unless the physician ordering a DNA Specimen Provenance Assay (DSPA) test recommends otherwise, a DSPA test furnished with respect to a positive prostate cancer biopsy shall be deemed to be medically necessary for purposes of Medicare.
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Aug. 1, 2016 |
Referred to the Subcommittee on Health.
|
July 13, 2016 |
Referred to House Ways and Means
|
July 13, 2016 |
Referred to House Energy and Commerce
|
July 13, 2016 |
Introduced in the House by Larry Bucshon (R-Ind.) |